S&P 500:  2,690.72  -45.55 (-1.66%)
DOW:  24,991.14  -422.08 (-1.66%)
NASDAQ:  7,058.00  -190.00 (-2.62%)

NASDAQ:AMGN - Amgen News Headlines

Sign in or create an account to add this stock to your watchlist.
Get Started
$193.68 -0.50 (-0.26 %)
(As of 11/19/2018 12:13 PM ET)
Previous Close$194.18
Today's Range$193.66 - $196.76
52-Week Range$163.31 - $210.19
Volume83,108 shs
Average Volume3.23 million shs
Market Capitalization$123.74 billion
P/E Ratio15.57
Dividend Yield2.72%
Beta1.37

Headlines

Amgen (NASDAQ AMGN) News Headlines

Source:
DateHeadline
Barrons Picks And Pans: Apple, Amgen, TreeHouse Foods And MoreBarron's Picks And Pans: Apple, Amgen, TreeHouse Foods And More
www.msn.com - November 17 at 5:21 PM
Amgen Stock Is Cheap and Generates Loads of CashAmgen Stock Is Cheap and Generates Loads of Cash
www.barrons.com - November 16 at 5:44 PM
Amgen (AMGN) Receives CHMP Positive Opinion To Expand Use Of BLINCYTO In Patients With Minimal Residual Disease-Positive B-Cell Precursor ALLAmgen (AMGN) Receives CHMP Positive Opinion To Expand Use Of BLINCYTO In Patients With Minimal Residual Disease-Positive B-Cell Precursor ALL
www.streetinsider.com - November 16 at 5:44 PM
European advisory group reverses position, now backs Amgens Blincyto for type of ALL; shares up 1%European advisory group reverses position, now backs Amgen's Blincyto for type of ALL; shares up 1%
seekingalpha.com - November 16 at 5:44 PM
Amgen Gets CHMP Positive Opinion To Expand Use Of BLINCYTOAmgen Gets CHMP Positive Opinion To Expand Use Of BLINCYTO
www.nasdaq.com - November 16 at 5:44 PM
Amgen Receives CHMP Positive Opinion To Expand Use Of BLINCYTO® (Blinatumomab) In Patients With Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic LeukemiaAmgen Receives CHMP Positive Opinion To Expand Use Of BLINCYTO® (Blinatumomab) In Patients With Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
finance.yahoo.com - November 16 at 5:44 PM
This Biotech Stock Is a Remedy for Tougher TimesThis Biotech Stock Is a Remedy for Tougher Times
finance.yahoo.com - November 16 at 5:44 PM
FY2021 EPS Estimates for Amgen, Inc. Lowered by Analyst (AMGN)FY2021 EPS Estimates for Amgen, Inc. Lowered by Analyst (AMGN)
www.americanbankingnews.com - November 15 at 7:58 AM
Neutral Media Coverage Somewhat Likely to Affect Amgen (AMGN) Share PriceNeutral Media Coverage Somewhat Likely to Affect Amgen (AMGN) Share Price
www.americanbankingnews.com - November 14 at 9:31 PM
Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 15, 2018Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 15, 2018
www.nasdaq.com - November 14 at 5:32 PM
Leerink Swann Research Analysts Lower Earnings Estimates for Amgen, Inc. (AMGN)Leerink Swann Research Analysts Lower Earnings Estimates for Amgen, Inc. (AMGN)
www.americanbankingnews.com - November 14 at 7:42 AM
Amgen (AMGN) Stock Moves -0.83%: What You Should KnowAmgen (AMGN) Stock Moves -0.83%: What You Should Know
www.zacks.com - November 13 at 8:02 AM
Amgens Repatha shows durable treatment effect in long-term studyAmgen's Repatha shows durable treatment effect in long-term study
seekingalpha.com - November 12 at 5:21 PM
Amgen Presents Results Highlighting The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In The Longest Duration Study Of A PCSK9 Inhibitor To Date At AHA Scientific Sessions 2018Amgen Presents Results Highlighting The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In The Longest Duration Study Of A PCSK9 Inhibitor To Date At AHA Scientific Sessions 2018
finance.yahoo.com - November 12 at 5:21 PM
Amgen Is Showing Independent Strength in a Bullish Sign for the FutureAmgen Is Showing Independent Strength in a Bullish Sign for the Future
finance.yahoo.com - November 12 at 5:21 PM
Amgen Foundation Pledges $500,000 In Relief To Victims Of Ventura And Los Angeles County WildfiresAmgen Foundation Pledges $500,000 In Relief To Victims Of Ventura And Los Angeles County Wildfires
finance.yahoo.com - November 12 at 9:19 AM
Zacks: Analysts Anticipate Amgen, Inc. (AMGN) Will Post Quarterly Sales of $5.87 BillionZacks: Analysts Anticipate Amgen, Inc. (AMGN) Will Post Quarterly Sales of $5.87 Billion
www.americanbankingnews.com - November 11 at 8:00 AM
Amgen (AMGN) Getting Somewhat Negative News Coverage, Study ShowsAmgen (AMGN) Getting Somewhat Negative News Coverage, Study Shows
www.americanbankingnews.com - November 10 at 7:52 PM
Amgen, Inc. (AMGN) Receives Consensus Rating of "Hold" from BrokeragesAmgen, Inc. (AMGN) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 9 at 1:30 AM
Zacks: Analysts Anticipate Amgen, Inc. (AMGN) Will Announce Earnings of $3.25 Per ShareZacks: Analysts Anticipate Amgen, Inc. (AMGN) Will Announce Earnings of $3.25 Per Share
www.americanbankingnews.com - November 9 at 1:18 AM
Coherus prices biosimilar to Amgens Neulasta at 33 pct discountCoherus prices biosimilar to Amgen's Neulasta at 33 pct discount
finance.yahoo.com - November 8 at 5:40 PM
The Latest: FBI seeks California shooter's frame of mindThe Latest: FBI seeks California shooter's frame of mind
finance.yahoo.com - November 8 at 5:40 PM
Here's Why bluebird bio Fell 21.4% in OctoberHere's Why bluebird bio Fell 21.4% in October
finance.yahoo.com - November 8 at 8:25 AM
Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar WoesAmgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes
finance.yahoo.com - November 7 at 5:44 PM
Why We Pass On AmgenWhy We Pass On Amgen
seekingalpha.com - November 6 at 5:37 PM
Amgen (AMGN) Earning Neutral News Coverage, Study FindsAmgen (AMGN) Earning Neutral News Coverage, Study Finds
www.americanbankingnews.com - November 6 at 3:26 PM
Amgen (AMGN) Outpaces Stock Market Gains: What You Should KnowAmgen (AMGN) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - November 6 at 8:01 AM
Amgen Announces Presentation Of Research Reinforcing The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In High-Risk Patients At AHA Scientific Sessions 2018Amgen Announces Presentation Of Research Reinforcing The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In High-Risk Patients At AHA Scientific Sessions 2018
finance.yahoo.com - November 5 at 5:38 PM
Amgen, Inc. (AMGN) to Post FY2018 Earnings of $14.25 Per Share, William Blair ForecastsAmgen, Inc. (AMGN) to Post FY2018 Earnings of $14.25 Per Share, William Blair Forecasts
www.americanbankingnews.com - November 5 at 2:34 AM
3 Top Biotech Stocks With P/Es Below 143 Top Biotech Stocks With P/Es Below 14
finance.yahoo.com - November 3 at 5:29 PM
Equities Analysts Issue Forecasts for Amgen, Inc.s FY2020 Earnings (AMGN)Equities Analysts Issue Forecasts for Amgen, Inc.'s FY2020 Earnings (AMGN)
www.americanbankingnews.com - November 2 at 12:51 PM
Amgen, Inc. (AMGN) Forecasted to Post Q4 2019 Earnings of $3.39 Per ShareAmgen, Inc. (AMGN) Forecasted to Post Q4 2019 Earnings of $3.39 Per Share
www.americanbankingnews.com - November 2 at 12:48 PM
Amgen, Inc. to Post Q4 2018 Earnings of $3.18 Per Share, Jefferies Financial Group Forecasts (AMGN)Amgen, Inc. to Post Q4 2018 Earnings of $3.18 Per Share, Jefferies Financial Group Forecasts (AMGN)
www.americanbankingnews.com - November 2 at 11:22 AM
Amgen (AMGN) Q3 Earnings and Revenues Beat EstimatesAmgen (AMGN) Q3 Earnings and Revenues Beat Estimates
finance.yahoo.com - November 1 at 5:36 PM
Amgen To Present New Data Showcasing Extensive Portfolio And Exciting Early Oncology Pipeline At ASH 2018Amgen To Present New Data Showcasing Extensive Portfolio And Exciting Early Oncology Pipeline At ASH 2018
finance.yahoo.com - November 1 at 5:36 PM
Citigroup Increases Amgen (AMGN) Price Target to $204.00Citigroup Increases Amgen (AMGN) Price Target to $204.00
www.americanbankingnews.com - November 1 at 5:12 PM
Amgen (AMGN) Receives Neutral Rating from Royal Bank of CanadaAmgen (AMGN) Receives Neutral Rating from Royal Bank of Canada
www.americanbankingnews.com - November 1 at 2:31 PM
Amgen, Inc. Expected to Earn FY2018 Earnings of $14.33 Per Share (AMGN)Amgen, Inc. Expected to Earn FY2018 Earnings of $14.33 Per Share (AMGN)
www.americanbankingnews.com - November 1 at 8:18 AM
Amgen, Inc. (AMGN) Expected to Earn FY2018 Earnings of $14.17 Per ShareAmgen, Inc. (AMGN) Expected to Earn FY2018 Earnings of $14.17 Per Share
www.americanbankingnews.com - November 1 at 8:18 AM
Amgen, Inc. (AMGN) Expected to Earn FY2018 Earnings of $14.26 Per ShareAmgen, Inc. (AMGN) Expected to Earn FY2018 Earnings of $14.26 Per Share
www.americanbankingnews.com - November 1 at 8:18 AM
Amgen beats by $0.24, beats on revenueAmgen beats by $0.24, beats on revenue
seekingalpha.com - October 31 at 5:39 PM
Amgen posts higher quarterly EPS, Repatha sales fall shortAmgen posts higher quarterly EPS, Repatha sales fall short
www.reuters.com - October 31 at 5:39 PM
Amgen (AMGN) Tops Q3 EPS by 24c, FY Guidance Tops ViewsAmgen (AMGN) Tops Q3 EPS by 24c, FY Guidance Tops Views
www.streetinsider.com - October 31 at 5:39 PM
Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises ViewAmgen (AMGN) Beats on Earnings & Sales in Q3, Raises View
finance.yahoo.com - October 31 at 5:39 PM
Edited Transcript of AMGN earnings conference call or presentation 30-Oct-18 9:00pm GMTEdited Transcript of AMGN earnings conference call or presentation 30-Oct-18 9:00pm GMT
finance.yahoo.com - October 31 at 5:39 PM
Amgen (AMGN) PT Set at $213.00 by Morgan StanleyAmgen (AMGN) PT Set at $213.00 by Morgan Stanley
www.americanbankingnews.com - October 31 at 4:24 PM
Goldman Sachs Group Analysts Give Amgen (AMGN) a $221.00 Price TargetGoldman Sachs Group Analysts Give Amgen (AMGN) a $221.00 Price Target
www.americanbankingnews.com - October 31 at 4:24 PM
Amgen (AMGN) Given a $224.00 Price Target by Oppenheimer AnalystsAmgen (AMGN) Given a $224.00 Price Target by Oppenheimer Analysts
www.americanbankingnews.com - October 31 at 12:54 PM
Amgen (AMGN) Given New $182.00 Price Target at Royal Bank of CanadaAmgen (AMGN) Given New $182.00 Price Target at Royal Bank of Canada
www.americanbankingnews.com - October 31 at 12:03 PM
Cantor Fitzgerald Reiterates "Hold" Rating for Amgen (AMGN)Cantor Fitzgerald Reiterates "Hold" Rating for Amgen (AMGN)
www.americanbankingnews.com - October 31 at 11:29 AM
This page was last updated on 11/19/2018 by MarketBeat.com Staff

Featured Article: Stock Split
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel